Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach.
González-Domínguez I, Puente-Massaguer E, Abdeljawad A, Lai TY, Liu Y, Loganathan M, Francis B, Lemus N, Dolange V, Boza M, Slamanig S, Martínez-Guevara JL, Krammer F, Palese P, Sun W.
González-Domínguez I, et al. Among authors: sun w.
NPJ Vaccines. 2024 Nov 17;9(1):222. doi: 10.1038/s41541-024-01014-8.
NPJ Vaccines. 2024.
PMID: 39551795